Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade
Chi Yan(Vanderbilt University), Ann Richmond(Monroe Carell Jr. Children's Hospital), E. Premkumar Reddy(The Graduate Center, CUNY), Caroline A. Nebhan(VA Tennessee Valley Healthcare System), Joseph T. Roland(Vanderbilt University Medical Center), Gregory D. Ayers(Vanderbilt University Medical Center), Sheau‐Chiann Chen(Vanderbilt University Medical Center), Anna E. Vilgelm(The Ohio State University), Nabil Saleh(Ain Shams University), Rebecca L. Shattuck-Brandt(Vanderbilt University), Jinming Yang(Hershey (United States)), Douglas B. Johnson(Vanderbilt University Medical Center)
Cited by 39
Related Papers
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k
Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis
|Cancer Cell|2008|917
Drugging the 'undruggable' cancer targets
|Nature reviews. Cancer|2017|912